You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thyroid Associated Ophthalmopathies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Associated Ophthalmopathies Trial (Sodium selenate, Sugar pill)

Withdrawn
  • Thyroid Associated Ophthalmopathies
  • Sodium selenate
  • Sugar pill
  • (no location specified)
Aug 12, 2021

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Beverly Hills, California
  • +22 more
Jan 30, 2023

Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)

Completed
  • Thyroid Associated Orbitopathy
  • Cairo, Egypt
    Cairo University
Jul 15, 2022

Clinical Activity of TAO Using Periocular Images Taken by

Completed
  • Thyroid Eye Disease
  • taking periorbital selfie images using smartphones
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Feb 15, 2023

Associated With Mental Fatigue in Graves' Disease

Recruiting
  • Graves Disease
  • +4 more
    • Gothenburg, Sweden
      Department of Endocrinology, Sahlgrenska University Hospital
    Jan 4, 2023

    Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

    Recruiting
    • Thyroid Eye Disease
    • +11 more
    • Miami, Florida
    • +1 more
    Oct 31, 2023

    Thyroid Associated Ophthalmopathy Trial in Guangzhou (Doxycycline Hyclate)

    Recruiting
    • Thyroid Associated Ophthalmopathy
    • Doxycycline Hyclate
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Nov 7, 2021

    Thyroid Associated Ophthalmopathy Trial in Guangzhou (immunosuppressive agent)

    Recruiting
    • Thyroid Associated Ophthalmopathy
    • immunosuppressive agent
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Nov 7, 2021

    Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)

    Recruiting
    • Graves Ophthalmopathy
    • +8 more
    • Doxycycline hyclate
    • Placebo
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Nov 16, 2021

    Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)

    Not yet recruiting
    • Thyroid-Associated Ophthalmopathy
    • (no location specified)
    Mar 18, 2022

    Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)

    Recruiting
    • Pheochromocytoma
    • +7 more
    • Genetic screening
    • San Antonio, Texas
      University of Texas Health Science Center
    Aug 25, 2022

    Chronic Health Conditions in Down Syndrome-Associated Acute

    Not yet recruiting
    • Down Syndrome
    • +7 more
    • Neurological Assessments
    • +3 more
    • (no location specified)
    Jan 18, 2023

    Thyroid Associated Ophthalmopathy Trial in Guangzhou (combination of orbital compression surgery and strabismus surgery, orbital

    Not yet recruiting
    • Thyroid Associated Ophthalmopathy
    • combination of orbital compression surgery and strabismus surgery
    • orbital compression
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Jun 6, 2021

    Thyroid Associated Ophthalmopathy, Surgical Procedure, Unspecified Trial in Manresa (3D printing model/guide., Standard surgery)

    Recruiting
    • Thyroid Associated Ophthalmopathy
    • Surgical Procedure, Unspecified
    • 3D printing model/guide.
    • Standard surgery
    • Manresa, Barcelona, Spain
      Eduard Pedemonte Sarrias
    Mar 8, 2022

    Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)

    Recruiting
    • Graves Ophthalmopathy
    • +2 more
    • Simvastatin 40mg
    • Malmö, Sweden
      Dpt. of Endocrinology, SUS Malmö
    Nov 17, 2021

    Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

    Recruiting
    • Bone Sarcoma
    • +15 more
    • Aldesleukin
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation Trial in Villejuif (Trametinib,

    Active, not recruiting
    • Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Sep 27, 2021

    Kidney Medullary Carcinoma, Loss of INI 1 Protein Expression, Stage III Renal Cell Cancer AJCC v8 Trial in Houston (Ipilimumab,

    Active, not recruiting
    • Kidney Medullary Carcinoma
    • +3 more
    • Ipilimumab
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Ophthalmopathy, Thyroid-Associated Trial in Gothenburg, Mölndal, Stockholm (Rituximab, Iv Methylprednisolone, peroral

    Active, not recruiting
    • Ophthalmopathy, Thyroid-Associated
    • Gothenburg, Sweden
    • +4 more
    Sep 17, 2021

    International PPB/DICER1 Registry

    Recruiting
    • Pleuropulmonary Blastoma
    • +14 more
      • Minneapolis, Minnesota
        Children's Minnesota
      Aug 16, 2022

      Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)

      Completed
      • Thyroid Associated Ophthalmopathy
      • Hypercholesterolemia
      • Pisa, Italy
        Ospedale Cisanello-Endocrinology I and II
      Aug 12, 2021

      Thyroid Associated Ophthalmopathy Trial in Guangzhou (Glucocorticoids)

      Recruiting
      • Thyroid Associated Ophthalmopathy
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center, Sun Yat-sen University
      May 15, 2021

      Thyroid-Associated Ophthalmopathy Trial in Alicante (Lanreotide (Autogel formulation). Duration of treatment - 3 injections, 1

      Terminated
      • Thyroid-Associated Ophthalmopathy
      • Lanreotide (Autogel formulation). Duration of treatment - 3 injections, 1 every 28 days
      • Alicante, Spain
        Hospital General d'Alacant
      Jun 1, 2020

      A Gene Hunting Study for Familial Papillary Thyroid Cancer

      Recruiting
      • Thyroid
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Oct 13, 2022